Clinical Trials Browser

Recruiting × Genetic Testing × Breast × Clear all

NCT06058377 2026-05-27

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Phase 3 Recruiting

Anatomic Stage II Breast Cancer AJCC v8

NCT05649072 2026-05-22

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Phase NA Recruiting

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT04475640 2026-04-02

Cancer Genetic Testing in Ethnic Populations

Phase NA Recruiting

Brain Neoplasms, Breast Neoplasms, Neoplasms, Unknown Primary

NCT05694559 2026-02-19

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

Phase NA Recruiting

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT04494945 2026-01-23

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Phase NA Recruiting

27,500 enrolled

BreastGastrointestinalGynecologic

Carcinoma, Intraductal, Noninfiltrating, Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome

NCT02620852 2025-11-25

WISDOM

Phase NA Recruiting

100,000 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT04638725 2022-08-03

SIGHER

HER2-positive Breast Cancer